ASTM D 4516 : 2019
|
Standard Practice for Standardizing Reverse Osmosis Performance Data |
ASTM F 2103 : 2018
|
Standard Guide for Characterization and Testing of Chitosan Salts as Starting Materials Intended for Use in Biomedical and Tissue-Engineered Medical Product Applications |
ASTM F 2103 : 2001 : R2007
|
Standard Guide for Characterization and Testing of Chitosan Salts as Starting Materials Intended for Use in Biomedical and Tissue-Engineered Medical Product Applications |
ASTM F 2150 : 2013 : REDLINE
|
Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Tissue-Engineered Medical Products |
ASTM F 2027 : 2000
|
Standard Guide for Characterization and Testing of Substrate Materials for Tissue-Engineered Medical Products |
ASTM F 2315 : 2010
|
Standard Guide for Immobilization or Encapsulation of Living Cells or Tissue in Alginate Gels |
CFR 21(PTS200-299) : 0
|
FOOD AND DRUGS - FOOD AND DRUG ADMINISTRATION, CHAPTER 1 DEPARTMENT OF HEALTH AND HUMAN SERVICES - PARTS 200-299 |
ASTM F 2450 : 2009
|
Standard Guide for Assessing Microstructure of Polymeric Scaffolds for Use in Tissue Engineered Medical Products |
ASTM F 2150 : 2019
|
Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Regenerative Medicine and Tissue-Engineered Medical Products |
ASTM F 2739 : 2019
|
Standard Guide for Quantifying Cell Viability and Related Attributes within Biomaterial Scaffolds |
ASTM F 2064 : 2000 : R2006
|
Standard Guide for Characterization and Testing of Alginates as Starting Materials Intended for Use in Biomedical and Tissue-Engineered Medical Products Application |
AAMI STBK9 3 : 2001
|
STERILIZATION - PART 3: INDUSTRIAL PROCESS CONTROL |
ASTM F 2027 : 2016
|
Standard Guide for Characterization and Testing of Raw or Starting Materials for Tissue-Engineered Medical Products |
ASTM F 2383 : 2005
|
Standard Guide for Assessment of Adventitious Agents in Tissue Engineered Medical Products (TEMPs) |
ASTM F 2103 : 2001
|
Standard Guide for Characterization and Testing of Chitosan Salts as Starting Materials Intended for Use in Biomedical and Tissue-Engineered Medical Product Applications |
ASTM F 2064 : 2000 : R2006 : EDT 1
|
Standard Guide for Characterization and Testing of Alginates as Starting Materials Intended for Use in Biomedical and Tissue-Engineered Medical Products Application |
ASTM F 2739 : 2008
|
Standard Guide for Quantitating Cell Viability Within Biomaterial Scaffolds |
ASTM F 2064 : 2014
|
Standard Guide for Characterization and Testing of Alginates as Starting Materials Intended for Use in Biomedical and Tissue Engineered Medical Product Applications |
CFR 21(PTS800-1299) : 0
|
FOOD AND DRUGS - FOOD AND DRUG ADMINISTRATION, CHAPTER 1 DEPARTMENT OF HEALTH AND HUMAN SERVICES - PARTS 800-1299 |
ASTM F 2347 : 2003
|
Standard Guide for Characterization and Testing of Hyaluronan as Starting Materials Intended for Use in Biomedical and Tissue Engineered Medical Product Applications |
AAMI STBK9 1 : 2001
|
STERILIZATION - PART 1: STERILIZATION IN HEALTH CARE FACILITIES |
ASTM F 2064 : 2000
|
Standard Guide for Characterization and Testing of Alginates as Starting Materials Intended for Use in Biomedical and Tissue-Engineered Medical Products Application |
ASTM F 2383 : 2011 : REDLINE
|
Standard Guide for Assessment of Adventitious Agents in Tissue Engineered Medical Products (TEMPs) |
ASTM F 2027 : 2016 : REDLINE
|
Standard Guide for Characterization and Testing of Raw or Starting Materials for Tissue-Engineered Medical Products |
ASTM F 2214 : 2002
|
Standard Test Method forIn Situ Determination of Network Parameters of Crosslinked Ultra High Molecular Weight Polyethylene (UHMWPE) |
ASTM F 2103 : 2001 : R2007 : EDT 1
|
Standard Guide for Characterization and Testing of Chitosan Salts as Starting Materials Intended for Use in Biomedical and Tissue-Engineered Medical Product Applications |
ASTM F 2150 : 2013
|
Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Tissue-Engineered Medical Products |
ASTM F 2103 : 2011-03
|
GUIDE FOR CHARACTERIZATION AND TESTING OF CHITOSAN SALTS AS STARTING MATERIALS INTENDED FOR USE IN BIOMEDICAL AND TISSUE-ENGINEERED MEDICAL PRODUCT APPLICATIONS |
ASTM F 2064 : 2017 : REDLINE
|
Standard Guide for Characterization and Testing of Alginates as Starting Materials Intended for Use in Biomedical and Tissue Engineered Medical Product Applications |
ASTM F 2315 : 2011
|
Standard Guide for Immobilization or Encapsulation of Living Cells or Tissue in Alginate Gels |
ASTM F 2150 : 2002 : EDT 1
|
Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Tissue-Engineered Medical Products |
ASTM F 2450 : 2004
|
Standard Guide for Assessing Microstructure of Polymeric Scaffolds for Use in Tissue Engineered Medical Products |
ASTM D 4516 : 2000
|
Standard Practice for Standardizing Reverse Osmosis Performance Data |
ASTM F 2027 : 2000 : EDT 1
|
Standard Guide for Characterization and Testing of Substrate Materials for Tissue-Engineered Medical Products |
ASTM F 2214 : 2016 : REDLINE
|
Standard Test Method for In Situ Determination of Network Parameters of Crosslinked Ultra High Molecular Weight Polyethylene (UHMWPE) |
ASTM F 748 : 2016 : REDLINE
|
Standard Practice for Selecting Generic Biological Test Methods for Materials and Devices |
ASTM D 4516 : 2000 : R2006 : EDT 1
|
Standard Practice for Standardizing Reverse Osmosis Performance Data |
ASTM F 2027 : 2008
|
Standard Guide for Characterization and Testing of Raw or Starting Biomaterials for Tissue-Engineered Medical Products |
ASTM F 2064 : 2017
|
Standard Guide for Characterization and Testing of Alginates as Starting Materials Intended for Use in Biomedical and Tissue Engineered Medical Product Applications |
ASTM F 2347 : 2015 : REDLINE
|
Standard Guide for Characterization and Testing of Hyaluronan as Starting Materials Intended for Use in Biomedical and Tissue Engineered Medical Product Applications |
ASTM F 2103 : 2011
|
Standard Guide for Characterization and Testing of Chitosan Salts as Starting Materials Intended for Use in Biomedical and Tissue-Engineered Medical Product Applications |
ASTM F 2739 : 2016
|
Standard Guide for Quantifying Cell Viability within Biomaterial Scaffolds |
ASTM D 4516 : 2000 : R2010
|
Standard Practice for Standardizing Reverse Osmosis Performance Data (Withdrawn 2019) |
CFR 21(PTS600-799) : 0
|
FOOD AND DRUGS - FOOD AND DRUG ADMINISTRATION, CHAPTER 1 DEPARTMENT OF HEALTH AND HUMAN SERVICES - PARTS 600-799 |
ASTM F 2103 : 2001 : R2007 : EDT 2
|
Standard Guide for Characterization and Testing of Chitosan Salts as Starting Materials Intended for Use in Biomedical and Tissue-Engineered Medical Product Applications |
ASTM F 2450 : 2018
|
Standard Guide for Assessing Microstructure of Polymeric Scaffolds for Use in Tissue-Engineered Medical Products |
AAMI STBK9 2 : 2001
|
STERILIZATION - PART 2: STERILIZATION EQUIPMENT |
ASTM F 2347 : 2011
|
Standard Guide for Characterization and Testing of Hyaluronan as Starting Materials Intended for Use in Biomedical and Tissue Engineered Medical Product Applications |
ASTM F 2315 : 2003
|
Standard Guide for Immobilization or Encapsulation of Living Cells or Tissue in Alginate Gels |
ASTM F 2150 : 2007
|
Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Tissue-Engineered Medical Products |
ASTM F 2315 : 2018
|
Standard Guide for Immobilization or Encapsulation of Living Cells or Tissue in Alginate Gels |
ASTM F 2347 : 2015
|
Standard Guide for Characterization and Testing of Hyaluronan as Starting Materials Intended for Use in Biomedical and Tissue Engineered Medical Product Applications |
ASTM F 2214 : 2002 : R2008
|
Standard Test Method for In Situ Determination of Network Parameters of Crosslinked Ultra High Molecular Weight Polyethylene (UHMWPE) |
ASTM F 2383 : 2011
|
Standard Guide for Assessment of Adventitious Agents in Tissue Engineered Medical Products (TEMPs) (Withdrawn 2020) |
ASTM F 2214 : 2016
|
Standard Test Method for In Situ Determination of Network Parameters of Crosslinked Ultra High Molecular Weight Polyethylene (UHMWPE) |
ASTM F 2450 : 2010
|
Standard Guide for Assessing Microstructure of Polymeric Scaffolds for Use in Tissue Engineered Medical Products |